Author:
Legan M.,Osredkar J.,Fisker S.,Kocijančič A.
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference30 articles.
1. Zborowski J V, Cauley JA, Talbott EO, Guzick DS, Winters SJ. Bone mineral density, androgens and the polycystic ovary: the complex and controversial issue of androgenic influence in female bone. J Clin Endocrinol Metab 2000, 85: 3496–506.
2. Homburg R. Involvement of growth factors in the pathophysiology of polycystic ovary syndrome. Gynecol Endocrinol 1998, 12: 391–7.
3. Morales AJ, Laughlin GA, Butzow T, Maheshwari H, Baumann G, Yen SSC. Insulin, somatotropic and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features. J Clin Endocrinol Metab 1996, 81: 2854–64.
4. Legan M, Kocijančič A, Preželj J, Osredkar J, Fisker S. GHIGF-I axis in non-obese women with functional hyperan-drogenism. J Endocrinol Invest 2002, 25: 691–5.
5. Saaf M, Hilding A, Thoren M, Troell S, Hall K. Growth hormone treatment of osteoporotic postmenopausal women — a one-year placebo-controlled study. Eur J Endocrinol 1999, 140: 390–9.